ERBB2 and breast cancer: Beyond breast cancer, tumors overexpressing EGFR include lung, glioblastoma, and colorectal cancers80, and tumors that can overexpress HER2 include gastric, ovarian, endometrial, bladder, lung, colon, and head and neck cancers81.